⌘K
t
Hikma Pharmaceuticals PLC announced on 15 May 2026 a change to its registered office address. The new address, effective immediately, is 10 Portman Square, London, W1H 6AZ.
| Date | 15 May 2026 |
| Time | 09:45:01 |
| Category | Corporate updates |
| ID | 4091E |
Hikma Pharmaceuticals PLC
(the Company)
Change of Registered Office Address
LONDON, 15 May 2026 - Hikma Pharmaceuticals PLC announces that its registered office address has changed with immediate effect to 10 Portman Square, London, W1H 6AZ.
- ENDS -
Enquiries
|
Hikma Pharmaceuticals PLC
|
|
|
Helen Middlemist Group Company Secretary |
+44 20 7399 2760 |
About Hikma
Hikma helps put better health within reach every day for millions of people around the world. For more than 45 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across North America, the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 9,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI:549300BNS685UXH4JI75) (rated BBB/stable S&P, BBB/stable Fitch)